Abstract
Hepatitis C virus (HCV) is a blood-borne and sexually transmitted single-stranded RNA flavivirus that causes a broad spectrum of liver disease, ranging from acute to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The worldwide prevalence of HCV positivity is highly variable. Hepatitis C infection is associated with a wide variety of renal diseases but the most common pattern of renal injury is Membranoproliferative glomerulonephritis (>50% of cases). This chapter reviews the epidemiology, pathogenesis, clinical and laboratory manifestations, pathology, and differential diagnosis of HCV-associated cryoglobulinemic. Therapeutic approaches to the management of patients with nephritic, nephritic, and vasculitic manifestations are also briefly considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5(9):558–567
Lapinski TW, Parfieniuk A, Rogalska-Plonska M et al (2009) Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int 29(8):1158–1161
Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42(4):631–657
Yamabe H, Johnson RJ, Gretch DR et al (1995) Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6(2):220–223
Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN (2002) Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36(4 Pt 1):978–985
Giordano TP, Henderson L, Landgren O et al (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297(18):2010–2017
Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33(6):355–374
Horcajada JP, GarcÃa-Bengoechea M, Cilla G et al (1999) Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 31(5):352–358
Dammacco F, Sansonno D (1992) Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 87(3):352–356
Ferri C, Greco F, Longombardo G et al (1991) Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol 9(6):621–624
Disdier P, Harlé JR, Weiller PJ (1991) Cryoglobulinaemia and hepatitis C infection. Lancet 338(8775):1151–1152
Ferri C, Greco F, Longombardo G et al (1991) Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 9(1):95–96
Kamar N, Izopet J, Alric L et al (2008) Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 69(3):149–160
Roccatello D, Fornasieri A, Giachino O et al (2007) Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49(1):69–82
Cacoub P, Renou C, Kerr G et al (2001) Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44(9):2118–2124
Renou C, Halfon P, Pol S et al (2002) Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 51(4):585–590
Ferri C (2008) Mixed cryoglobulinemia. Orphanet J Rare Dis 3:25
Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15(11):2078–2085
Rostagno AA, Gallo G, Gold LI (2002) Binding of polymeric IgG to fibronectin in extracellular matrices: an in vitro paradigm for immune-complex deposition. Mol Immunol 38(15):1101–1111
Fornasieri A, Armelloni S, Bernasconi P et al (1996) High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 27(4):476–483
RodrÃguez-Iñigo E, Casqueiro M, Bartolomé J et al (2000) Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J Viral Hepat 7(1):23–29
Sansonno D, Gesualdo L, Manno C et al (1997) Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25(5):1237–1244
Sabry AA, Sobh MA, Irving WL et al (2002) A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 17(2):239–245
Wornle M, Schmid H, Banas B et al (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168(2):370–385
Alpers CE, Kowalewska J (2007) Emerging paradigms in the renal pathology of viral diseases. Clin J Am Soc Nephrol 2(Suppl 1):S6–S12
Tarantino A, Campise M, Banfi G et al (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47(2):618–623
D’Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650–671
Davda R, Peterson J, Weiner R, Croker B, Lau JY (1993) Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 22(3):452–455
Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ (1999) Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 81(1):37–40
Pouria S, Feehally J (1999) Glomerular IgA deposition in liver disease. Nephrol Dial Transplant 14(10):2279–2282
Markowitz GS, Cheng JT, Colvin RB et al (1998) Hepatitis C viral infection is associated with fibrillary Âglomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 9(12):2244–2252
Peter H, Savage C (2003) Idiopathic membranoproliferative glomerulonephritis. In: Therapy in nephrology and hypertension. Saunders, Philadelphia, pp 247–252
Fabrizi F, Lunghi G, Messa P, Martin P (2008) Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813–825
Perico N, Cattaneo D, Bikbov B, Remuzzi G (2009) Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207–220
Johnson RJ, Gretch DR, Couser WG et al (1994) Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46(6):1700–1704
Alric L, Plaisier E, Thébault S et al (2004) Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 43(4):617–623
McHutchison JG, Gordon SC, Schiff ER et al (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339(21):1485–1492
Bruchfeld A, Lindahl K, Schvarcz R, Ståhle L (2002) Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 24(6):701–708
Bruchfeld A, Lindahl K, Reichard O (2006) Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat 13(5):316–321
Beddhu S, Bastacky S, Johnson JP (2002) The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81(5):398–409
Saadoun D, Resche-Rigon M, Sene D et al (2008) Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis 67(10):1431–1436
Saadoun D, Resche Rigon M, Sene D et al (2010) Rituximab plus Peg-Interferon {alpha}/ribavirin compared to Peg-interferon {alpha}/ribavirin in hepatitis C related mixed cryoglobulinemia. Blood 116(3):326–334, 2010 May 3 [cited 2010 May 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20439619
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Argyropoulos, C.P., Bastacky, S., Johnson, J.P. (2012). HCV-Associated Membranoproliferative Glomerulonephritis. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_22
Download citation
DOI: https://doi.org/10.1007/978-88-470-1705-4_22
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1704-7
Online ISBN: 978-88-470-1705-4
eBook Packages: MedicineMedicine (R0)